Open AccessEffects of Eradication of HCV on Cardiovascular Risk and Preclinical Atherosclerosis in HIV/HCV-Coinfected Patients
Author(s) -
Ana Carrero,
Juan Berenguer,
Víctor Hontañón,
Jordi Navarro,
José Hernández-Quero,
Marı́a José Galindo,
Carmen Quereda,
Ignacio Santos,
María J. Téllez,
Enrique Ortega,
José Sanz,
Luz María Medrano,
Leire PérezLatorre,
José María Bellón,
Salvador Resino,
Javier Bermejo,
Juan González-García
Publication year - 2020
Publication title -
journal of acquired immune deficiency syndromes
Language(s) - English
Resource type - Journals
eISSN - 1944-7884
pISSN - 1525-4135
DOI - 10.1097/qai.0000000000002260
Subject(s) - medicine , ribavirin , pulse wave velocity , pegylated interferon , gastroenterology , hepatitis c virus , hepatitis c , prospective cohort study , immunology , blood pressure , virus
To assess the effects of eradication of hepatitis C virus (HCV) on cardiovascular risk (CVR) and preclinical atherosclerosis in HIV/HCV-coinfected patients.